These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31897259)

  • 41. Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care.
    Schultz JL; Horner KE; McDanel DL; Miller ML; Beranek RL; Jacobsen RB; Sly NJ; Miller AC; Mascardo LA
    J Pharm Pract; 2018 Jun; 31(3):268-271. PubMed ID: 28532224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment.
    Ray S; Lokken J; Whyte C; Baumann A; Oldani M
    J Interprof Care; 2020; 34(1):27-35. PubMed ID: 31381470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria.
    David EA; Soremekun RO; Abah IO; Aderemi-Williams RI
    Pharm Pract (Granada); 2021; 19(3):2402. PubMed ID: 34457094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
    Sherrill CH; Houpt CT; Dixon EM; Richter SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes.
    Lingow SE; Guyton JE
    J Am Pharm Assoc (2003); 2020; 60(5):734-739. PubMed ID: 32280024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
    Pousinho S; Morgado M; Falcão A; Alves G
    J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Initiating a GLP1 Agonist and/or SGLT2 Inhibitor Therapy on De-Escalation and Discontinuation of Insulin and Diabetes Control When Managed by an Interprofessional Collaborative Team.
    Champion M; Wills Avila G; Garcia AE; Álvarez Delgado FM; Valdez CA
    J Prim Care Community Health; 2024; 15():21501319241231398. PubMed ID: 38353180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
    Hui RL; Chang CC; Niu F; Tang YK; Harano D; Deguzman L; Kao DJ; Awsare S; Draves M
    J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacist telehealth in an underserved urban population with type 2 diabetes mellitus.
    Mukherjee SM; DelDotto D; Patel A; Silva MA
    Res Social Adm Pharm; 2023 Nov; 19(11):1465-1470. PubMed ID: 37507339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial.
    Sharp LK; Tilton JJ; Touchette DR; Xia Y; Mihailescu D; Berbaum ML; Gerber BS
    Pharmacotherapy; 2018 Jan; 38(1):58-68. PubMed ID: 29121408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of pharmacist intervention to improve medication access for patients with diabetes.
    Bias AA; Hiday RA; Kline MM
    J Am Pharm Assoc (2003); 2023; 63(4S):S25-S30. PubMed ID: 36621403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of clinical pharmacist-led smartphone application on medication adherence, insulin injection technique and glycemic control for women with gestational diabetes receiving multiple daily insulin injection: A randomized clinical trial.
    Zhuo Y; Pan Y; Lin K; Yin G; Wu Y; Xu J; Cai D; Xu L
    Prim Care Diabetes; 2022 Apr; 16(2):264-270. PubMed ID: 35168915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
    Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prandial insulin versus glucagon-like peptide-1 added to basal insulin: comparative effectiveness in the community practice setting.
    Digenio A; Karve S; Candrilli SD; Dalal M
    Postgrad Med; 2014 Oct; 126(6):49-59. PubMed ID: 25414934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting.
    Kallenbach L; Shui AM; Cheng WY; Fan T; Hu W; Zichlin ML; Duh MS; Ye F; Levin PA
    Endocr Pract; 2018 Sep; 24(9):805-814. PubMed ID: 29975575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a Conservative Pharmacist-led U-500R Insulin Management Protocol in the Primary Care Setting.
    Dumont C; Fitzgerald L; Valdez CA
    J Prim Care Community Health; 2020; 11():2150132720973827. PubMed ID: 33218271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial.
    Jameson JP; Baty PJ
    Am J Manag Care; 2010 Apr; 16(4):250-5. PubMed ID: 20394460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
    Moreau C; Sando KR; Zambrano DH
    Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.